Chicago Partners Investment Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $411K | Sell |
881
-98
| -10% | -$45.7K | 0.01% | 684 |
|
|
2025
Q1 | $399K | Buy |
979
+134
| +16% | +$54.7K | 0.01% | 595 |
|
|
2024
Q4 | $460K | Sell |
845
-156
| -16% | -$85K | 0.02% | 526 |
|
|
2024
Q3 | $577K | Buy |
1,001
+290
| +41% | +$167K | 0.02% | 453 |
|
|
2024
Q2 | $437K | Sell |
711
-44
| -6% | -$27.1K | 0.02% | 503 |
|
|
2024
Q1 | $434K | Buy |
755
+297
| +65% | +$171K | 0.02% | 488 |
|
|
2023
Q4 | $247K | Sell |
458
-146
| -24% | -$78.9K | 0.01% | 585 |
|
|
2023
Q3 | $279K | Buy |
604
+61
| +11% | +$28.2K | 0.02% | 527 |
|
|
2023
Q2 | $301K | Sell |
543
-34
| -6% | -$18.8K | 0.02% | 531 |
|
|
2023
Q1 | $331K | Buy |
577
+94
| +19% | +$53.9K | 0.02% | 488 |
|
|
2022
Q4 | $282K | Buy |
483
+39
| +9% | +$22.7K | 0.02% | 494 |
|
|
2022
Q3 | $219K | Buy |
444
+55
| +14% | +$27.1K | 0.02% | 513 |
|
|
2022
Q2 | $233K | Sell |
389
-20
| -5% | -$12K | 0.02% | 502 |
|
|
2022
Q1 | $222K | Buy |
409
+32
| +8% | +$17.4K | 0.02% | 490 |
|
|
2021
Q4 | $212K | Buy |
377
+39
| +12% | +$21.9K | 0.02% | 513 |
|
|
2021
Q3 | $213K | Buy |
+338
| New | +$213K | 0.01% | 535 |
|
|
2018
Q4 | – | Sell |
-300
| Closed | -$69K | – | 864 |
|
|
2018
Q3 | $69K | Hold |
300
| – | – | 0.01% | 474 |
|
|
2018
Q2 | $62K | Sell |
300
-121
| -29% | -$25K | 0.01% | 451 |
|
|
2018
Q1 | $87K | Buy |
421
+121
| +40% | +$25K | 0.01% | 369 |
|
|
2017
Q4 | $57K | Hold |
300
| – | – | 0.01% | 431 |
|
|
2017
Q3 | $57K | Sell |
300
-400
| -57% | -$76K | 0.01% | 423 |
|
|
2017
Q2 | $108K | Buy |
+700
| New | +$108K | 0.03% | 268 |
|
|
2016
Q1 | – | Sell |
-893
| Closed | -$127K | – | 481 |
|
|
2015
Q4 | $127K | Buy |
+893
| New | +$127K | 0.06% | 203 |
|